INTERNATIONAL PATENT: THERAVECTYS, INSTITUT PASTEUR FILES APPLICATION FOR "LENTIVIRAL VECTORS TARGETING KRAS NEOEPITOPES FOR CANCER IMMUNOTHERAPY"

GENEVA, April 18 -- THERAVECTYS (Bat Pasteur Biotop28 rue du Docteur Roux75015 PARIS), INSTITUT PASTEUR (28 rue du Docteur Roux75015 PARIS) filed a patent application (PCT/EP2025/078749) for "LENTIVIRAL VECTORS TARGETING KRAS NEOEPITOPES FOR CANCER IMMUNOTHERAPY" on Oct 07, 2025. With publication no. WO/2026/077941, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHARNEAU, Pierre (Laboratoire Commun Pasteur-TheraVectys - Departement de Virologie - Institut Pasteur28 rue du Dr Roux75724 PARIS CEDEX 15), MAJLESSI, Laleh (La...